Long-Term Results (Three to Five Years) of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Stenting (RIBS) Randomized Study
Fernando Alfonso, MD*,*,
José M. Augé, MD
,
,
Javier Zueco, MD
,
Armando Bethencourt, MD
,
José R. López-Mínguez, MD||,
José M. Hernández, MD¶,
Juan A. Bullones, MD#,
Isabel Calvo, MD**,
Enrique Esplugas, MD
,
María J. Pérez-Vizcayno, MD*,
Raul Moreno, MD*,
Cristina Fernández, MD*,
Rosana Hernández, MD*,
Vasco Gama-Ribeiro, MD
for the RIBS Investigators
* University Hospital Clinico San Carlos, Madrid, Spain
University Hospital Santa Cruz y San Pablo, Barcelona, Spain
University Hospital Marqués de Valdecilla, Santander, Spain
University Hospital Son Dureta, Palma de Mallorca, Spain
|| University Hospital Infanta-Cristina, Badajoz, Spain
¶ University Hospital Virgen de la Victoria, Malaga, Spain
# University Hospital Carlos Haya, Malaga, Spain
** University Hospital Miguel Servet, Zaragoza, Spain

University Hospital Bellvitge, Barcelona, Spain

University Hospital Vila Nova de Gaia, Porto, Portugal

University Hospital Deceased

View larger version (28K):
[in a new window]
|
Figure 1 Event-free survival (EFS) at four years. (A) Freedom from death, myocardial infarction, and target vessel revascularization. (B) Freedom from "cardiac" death, myocardial infarction, and target vessel revascularization. (C) Freedom from "cardiac" death or myocardial infarction. (D) Freedom from target vessel revascularization.
|
|

View larger version (20K):
[in a new window]
|
Figure 2 Clinical events according to the 10 prespecified variables. B/A = balloon-to-artery ratio; CI = confidence interval; LAD = left anterior descending coronary artery; RE = restenosis.
|
|

View larger version (18K):
[in a new window]
|
Figure 3 Event-free survival (EFS) (death, myocardial infarction, target vessel revascularization) in patients with large vessels according to treatment allocation.
|
|
Copyright © 2005 by the American College of Cardiology Foundation.